Loading stock data…
Solventum Corporation (SOLV)
$90.11-1.58 (-1.72%)
Market ClosedLast close Sep 8
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Solventum Corporation in the Healthcare sector is trading at $90.11 with a market capitalization of $15.6B. Wall Street consensus targets $93.92 (13 analysts), implying a +4.2% move over the next 12 months. The stock is currently near its 52-week high of $94.16, remaining 16.3% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.01B↑ | $2.00B↓ | $2.10B↓ | $2.16B↑ | $2.07B |
| Gross Profit | $1.09B↑ | $1.03B↓ | $1.14B↓ | $1.18B↑ | $1.11B |
| Operating Income | $79.00M↓ | $93.00M↓ | $172.00M↓ | $214.00M↑ | $152.00M |
| Net Income | $13.00M↓ | $63.00M↓ | $1.27B↑ | $90.00M↓ | $137.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Den...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$15.61B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
11.21
Beta
Defensive asset. Lower volatility than the S&P 500.
0.69
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
29.88%
Volume
Today's trading volume
1.10M
Recent News
Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?
Solventum (SOLV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
2 Mid-Cap Stocks to Consider Right Now and 1 That Underwhelm
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?
Solventum's growth, higher earnings outlook and cost cuts strengthen its case, but heavy debt and 2027 margin risks temper the upside.
3 Reasons to Avoid SOLV and 1 Stock to Buy Instead
Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Value Stocks with Open Questions
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.